| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.6B | $0.3B | $2.0B | $1.7B | $0.4B | $0.4B | $0.4B | $0.3B |
| Cost of Revenue | — | — | — | — | $0.7B | $0.6B | $0.6B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-1.1B | $0.1B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B | $0.0B |
| Net Income | $-0.0B | $0.1B | $0.2B | $0.1B | $-0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $-1.24 | $3.94 | $7.17 | $3.87 | $-0.17 | $0.86 | $0.95 | $1.19 |
| EPS (Diluted) | $-1.24 | $3.93 | $7.14 | $3.85 | $-0.17 | $0.85 | $0.95 | $1.18 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.8B | $3.0B | $1.2B | $1.1B | $1.0B | $1.0B | $0.8B | $0.7B |
| Current Assets | $0.5B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Cash & Equivalents | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.4B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Stockholders' Equity | $0.2B | $0.8B | $0.7B | $0.6B | $0.5B | $0.6B | $0.6B | $0.5B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | — | $0.2B | $0.2B | $0.1B |
| Investing Cash Flow | — | — | — | — | — | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | — | — | — | — | — | $-0.1B | $-0.1B | $-0.0B |